|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis显示文摘 | Richard Moreau Rajiv Jalan Pere Gines Marco Pavesi Paolo Angeli Juan Cordoba Francois Durand Thierry Gustot Faouzi Saliba Marco Domenicali Alexander Gerbes Julia Wendon Carlo Alessandria Wim Laleman Stefan Zeuzem Jonel Trebicka Mauro Bernardi Vicente Arro | 2013 | Gastroenterology2013，，7： | 12 |
| 2 | Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis显示文摘 | Jonel Trebicka Evrim Anadol Natalia Elfimova Ingo Strack Michael Roggendorf Sergei Viazov Inga Wedemeyer Uta Drebber Jürgen Rockstroh Tilman Sauerbruch Hans-Peter Dienes Margarete Odenthal | 2012 | Journal of Hepatology2012，，： | 2 |
| 3 | Defective RhoA/Rho-Kinase Signaling Contributes to Vascular Hypocontractility and Vasodilation in Cirrhotic Rats显示文摘 | Martin Hennenberg Erwin Biecker Jonel Trebicka Kerstin Jochem Qi Zhou Martina Schmidt Karl H. Jakobs Tilman Sauerbruch J?rg Heller | 2006 | Gastroenterology2006，，3： | 1 |
| 4 | The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients显示文摘 | Hans Dieter Nischalke Cordula Berger Carolin Luda Tobias Müller Thomas Berg Martin Coenen Benjamin Kr?mer Christian K?rner Jonel Trebicka Frank Grünhage Frank Lammert Jacob Nattermann Tilman Sauerbruch Ulrich Spengler | 2011 | Journal of Hepatology2011，，4： | 1 |
| 5 | Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis显示文摘 | Richard Moreau Rajiv Jalan Pere Gines Marco Pavesi Paolo Angeli Juan Cordoba Francois Durand Thierry Gustot Faouzi Saliba Marco Domenicali Alexander Gerbes Julia Wendon Carlo Alessandria Wim Laleman Stefan Zeuzem Jonel Trebicka Mauro Bernardi Vicente Arro | 2013 | Gastroenterology2013，，7： | 1 |
| 6 | Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis显示文摘 | Richard Moreau Rajiv Jalan Pere Gines Marco Pavesi Paolo Angeli Juan Cordoba Francois Durand Thierry Gustot Faouzi Saliba Marco Domenicali Alexander Gerbes Julia Wendon Carlo Alessandria Wim Laleman Stefan Zeuzem Jonel Trebicka Mauro Bernardi Vicente Arro | | Gastroenterology0，，： | 1 |
| 7 | Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilation in Cirrhosis显示文摘 | Josephine A. Grace Sabine Klein Chandana B. Herath Michaela Granzow Robert Schierwagen Noemi Masing Thomas Walther Tilman Sauerbruch Louise M. Burrell Peter W. Angus Jonel Trebicka | 2013 | Gastroenterology2013，，： | 1 |
| 8 | Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure显示文摘 | Rajiv Jalan Faouzi Saliba Marco Pavesi Alex Amoros Richard Moreau Pere Ginès Eric Levesque Francois Durand Paolo Angeli Paolo Caraceni Corinna Hopf Carlo Alessandria Ezequiel Rodriguez Pablo Solis-Mu?oz Wim Laleman Jonel Trebicka Stefan Zeuzem Thierry Gus | 2014 | Journal of Hepatology2014，，： | 1 |
| 9 | Good long‐term outcome of Budd‐Chiari syndrome with a step‐wise management显示文摘 | Susana Seijo Aurelie Plessier Jildou Hoekstra Alessandra Dell’Era Dalvinder Mandair Kinan Rifai Jonel Trebicka Isabelle Morard Luc Lasser Juan G. Abraldes Sarwa Darwish Murad J?rg Heller Antoine Hadengue Massimo Primignani Elwyn Elias Harry L.A. Janssen D | 2013 | Hepatology2013，，5： | 1 |
| 10 | Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats显示文摘 | Jonel Trebicka Ludger Leifeld Martin Hennenberg Erwin Biecker Andreas Eckhardt Nicolas Fischer Andrea Schulze Pr?bsting Christoph Clemens Frank Lammert Tilman Sauerbruch J?rg Heller | 2008 | Hepatology2008，，4： | 1 |
| 11 | Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis显示文摘 | Jonel Trebicka Evrim Anadol Natalia Elfimova Ingo Strack Michael Roggendorf Sergei Viazov Inga Wedemeyer Uta Drebber Jürgen Rockstroh Tilman Sauerbruch Hans-Peter Dienes Margarete Odenthal | 2012 | Journal of Hepatology2012，，： | 1 |
| 12 | CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt显示文摘 | Marie-Luise Berres Sonja Asmacher Jennifer Lehmann Christian Jansen Jan G?rtzen Sabine Klein Carsten Meyer Holger M. Strunk Rolf Fimmers Frank Tacke Christian P. Strassburg Christian Trautwein Tilman Sauerbruch Hermann Elard Wasmuth Jonel Trebicka | 2014 | Journal of Hepatology2014，，： | 1 |
| 13 | Defective RhoA/Rho-Kinase Signaling Contributes to Vascular Hypocontractility and Vasodilation in Cirrhotic Rats显示文摘 | Martin Hennenberg Erwin Biecker Jonel Trebicka Kerstin Jochem Qi Zhou Martina Schmidt Karl H. Jakobs Tilman Sauerbruch J?rg Heller | 2006 | Gastroenterology2006，，3： | 1 |
| 14 | HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects显示文摘 | Sabine Klein Marike Marjolijn Van Beuge Michaela Granzow Leonie Beljaars Robert Schierwagen Sibel Kilic Iren Heidari Sebastian Huss Tilman Sauerbruch Klaas Poelstra Jonel Trebicka | 2012 | Journal of Hepatology2012，，6： | 1 |
| 15 | Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure显示文摘Background:Cirrhosis with acute decompensation(AD)and acute-on-chronic liver failure(ACLF)are characterized by high morbidity and mortality.Cytolysin,a toxin from Enterococcus faecalis(E.faecalis),is associated with mortality in alcohol-associated hepatitis(AH).It is unclear whether cytolysin also contributes to disease severity in AD and ACLF.Methods:We studied the role of fecal cytolysin in 78 cirrhotic patients with AD/ACLF.Bacterial DNA from fecal samples was extracted and real-time quantitative polymerase chain reaction(PCR)was performed.The association between fecal cytolysin and liver disease severity in cirrhosis with AD or ACLF was analyzed.Results:Fecal cytolysin and E.faecalis abundance did not predict chronic liver failure(CLIF-C)AD and ACLF scores.Presence of fecal cytolysin was not associated with other liver disease markers,including Fibrosis-4(FIB-4)index,‘Age,serum Bilirubin,INR,and serum Creatinine(ABIC)’score,Child-Pugh score,model for end-stage liver disease(MELD)nor MELD-Na scores in AD or ACLF patients.Conclusions:Fecal cytolysin does not predict disease severity in AD and ACLF patients.The predictive value of fecal cytolysin positivity for mortality appears to be restricted to AH. | Phillipp Hartmann Sonja Lang Robert Schierwagen Sabine Klein Michael Praktiknjo Jonel Trebicka Bernd Schnabl | 2023 | Hepatobiliary & Pancreatic Diseases International2023，22，5： | 0 |
| 16 | 肝硬化患者门静脉血栓形成显示文摘门静脉血栓形成(PVT)在肝硬化患者中较为常见,尽管PVT相关的严重并发症(如肠系膜缺血)很罕见,但一旦出现足以危胁生命。目前PVT的临床意义、诊断和治疗仍未明确,尚处于探讨中。本文对PVT的分级、临床表现地域差异、诊断标准、病理生理及危险因素进行了阐述,对各种治疗方案和预防措施进行了评价,重点分析了各种方案/措施的缺陷。此外,我们还对PVT对预后的影响这一争议问题进行了探讨,着重考虑了肝移植和未来展望。 | Leona von Kockritz Andrea De Gottardi Jonel Trebicka Michael Praktiknjo | 2017 | Gastroenterology Report2017，5，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员